Hiromu Yano

An IL‐27/Stat3 axis induces expression of programmed cell death 1 ligands (<scp>PD</scp>‐L1/2) on infiltrating macrophages in lymphoma

Hasita Horlad, Chaoya Ma, Hiromu Yano et al. · Cancer Science · 2016 · 127 citations · Full text

High density of <scp>CD</scp>204‐positive macrophages predicts worse clinical prognosis in patients with breast cancer

Yuko Miyasato, Takuya Shiota, Koji Ohnishi et al. · Cancer Science · 2017 · 103 citations · Full text

SPP1 Derived from Macrophages Is Associated with a Worse Clinical Course and Chemo-Resistance in Lung Adenocarcinoma

Eri Matsubara, Yoshihiro Komohara, Shigeyuki Esumi et al. · Cancers · 2022 · 69 citations · Full text

Tumor-associated Macrophages, Lung Inflammation, Lung Adenocarcinoma +16

Aging-associated and CD4 T-cell–dependent ectopic CXCL13 activation predisposes to anti–PD-1 therapy-induced adverse events

Hirotake Tsukamoto, Yoshihiro Komohara, Yusuke Tomita et al. · Proceedings of the National Academy of Sciences · 2022 · 63 citations · Full text

The expression of PD-1 ligands and IDO1 by macrophage/microglia in primary central nervous system lymphoma

Yuko Miyasato, Yasuo Takashima, Hiroto Takeya et al. · Journal of Clinical and Experimental Hematopathology · 2018 · 46 citations · Full text

Immunology, Pathology, Cell Death +20